Hepatitis G virus and fulminant hepatic failure: Evidence for transfusion-related infection

Journal of Hepatology

Volumn 27, Issue 4, 1997, Pages 613-619

  Moaven, Len D ^a   Locarnini, Stephen A ^a   Bowden, D Scott ^a   Kim, Jungsuh P ^b   Breschkin, Alan ^a   McCaw, Rhonda ^a   Yun, Andersen ^b   Wages Jr, John ^b   Jones, Bob ^c   Angus, Peter ^c  

^a FAIRFIELD HOSPITAL   (Australia)

^b Genelabs Incorporated   (United States)

^c NONE

Author keywords

Fulminant hepatitis; GB virus C; Hepatitis G virus; Transfusion

Indexed keywords

ARTICLE; AUSTRALIA; BLOOD TRANSFUSION; CLINICAL ARTICLE; HEPATITIS G VIRUS; HUMAN; INFECTION RISK; LIVER FAILURE; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CHARACTERIZATION; VIRUS HEPATITIS;

EID: 0030865883     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80077-3     Document Type: Article

References (27)

1. Wright TL. Etiology of fulminant hepatic failure: is another virus involved? Gastroenterology. 104:1993;640-653.
2. Alter MJ, Bradley DW. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Semin Liver Dis. 15:1995;110-120.
3. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning all and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 271:1996;505-508.
4. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med. 1:1995;564-569.
5. Zuckerman AJ. Alphabet of hepatitis viruses (editorial). Lancet. 347:1996;558-559.
6. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet. 346:1995;1131-1132.
7. Tameda Y, Kosaka Y, Tagawa S, Takase K, Sawada N, Nakao H, et al. Infection with GB virus C (GBV-C) in patients with fulminant hepatitis. J Hepatol. 25:1996;842-847.
8. Kao HJ, Chen PJ, Chen DS. GBV-C in the aetiology of fulminant hepatitis. Lancet. 347:1996;120.
9. Mishiro S, Yoshiba M, Okamoto H. GBV-C in the aetiology of fulminant hepatitis. Lancet. 347:1996;120-121.
10. Kuroki T, Nishiguchi S, Tanaka M, Enomoto M, Kobayashi K. Does GBV-C cause fulminant hepatitis in Japan? Lancet. 347:1996;908.
11. Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure. Lancet. 347:1996;1552.
12. Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Boker K, Muerhoff AS, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet. 348:1996;1626-1629.
13. Angus PW, Locarnini SA, McCaughan GW, Jones RM, McMillan JS, Bowden DS. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology. 21:1995;14-18.
14. Crofts N, Hopper JL, Bowden DS, Breschkin AM, Milner R, Locarnini SA. Hepatitis C virus infection among a cohort of Victorain injecting drug users. Med J Aust. 159:1993;237-241.
15. Moaven LD, Van Asten M, Crofts N, Locarnini SA. The seroepidemiology of hepatitis E in selected Australian populations. J Med Virol. 45:1995;326-330.
16. Langnas AN, Markin RS, Cattral MS, Naides SJ. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anaemia. Hepatology. 22:1995;1661-1665.
17. Tang MLK, Kemp AS, Moaven LD. Parvovirus B19-associated red cell aplasia in combined immunodeficiency with normal immunoglobulins. Pediatr Infect Dis J. 13:1994;539-542.
18. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 339:1989;237-238.
19. Chemczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem. 167:1987;156-159.
20. Moaven LD, Hyland CA, Young IF, Bowden DS, McCaw R, Mison L, et al. Pervalence of hepatitis G virus in Queensland blood donors. Med J Aust. 165:1996;369-371.
21. Schlueter V, Schmolke S, Stark K, Hess G, Ofenloch-Haehnle B, Engel AM. Reverse transcription-PCR detection of hepatitis G virus. J Clin Microbiol. 34:1996;2660-2664.
22. Wright TL, Mamish D, Combs C, Kim M, Donegan E, Ferrell L, et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet. 339:1992;952-955.
23. Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G, et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet. 349:1997;318-320.
24. Pilot-Matias TJ, Carrick RJ, Coleman PF, Leary TP, Surowy TK, Simons JN, et al. Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector sysetm and its utility as a serologic marker. Virology. 225:1996;282-292.
25. Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lau JYN, et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology. 111:1996;1569-1575.
26. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenace haemodialysis. N Engl J Med. 334:1996;1485-1490.
27. Alter HJ, Nakatsuji Y, Melpolder J, Kiyosawa K, Wages J, Wesley R, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med. 336:1997;741-746.